Synlogic Inc (SYBX)

Synlogic Inc (SYBX) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $13M; returns 1 day +5.0%, 1 week +5.0%, 1 year -39.0%.

Synlogic Inc. (SYBX) is a biopharmaceutical company focused on developing Synthetic Biotic medicines, which are genetically engineered microbes designed to treat metabolic and inflammatory diseases. These medicines are engineered to act locally in the gastrointestinal (GI) tract to consume or modify disease-causing metabolites.

Groups SYBX belongs to

• Biotechnology
• Biopharmaceutical
• Clinical Stage
• Metabolic Disorders
• Clinical Stage Biotech
• Rare Diseases
• Healthcare

SYBX financial model: income statement, cash flow and balance sheet